NCT07768189
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07768189
Title A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma (TEMPO-1)
Acronym TEMPO-1
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Corbus Pharmaceuticals Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | AUT


No variant requirements are available.